Alasdair Parker

3.6k total citations
40 papers, 995 citations indexed

About

Alasdair Parker is a scholar working on Genetics, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Alasdair Parker has authored 40 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Molecular Biology and 8 papers in Psychiatry and Mental health. Recurrent topics in Alasdair Parker's work include Genomics and Rare Diseases (9 papers), Epilepsy research and treatment (7 papers) and Genomic variations and chromosomal abnormalities (6 papers). Alasdair Parker is often cited by papers focused on Genomics and Rare Diseases (9 papers), Epilepsy research and treatment (7 papers) and Genomic variations and chromosomal abnormalities (6 papers). Alasdair Parker collaborates with scholars based in United Kingdom, United States and Netherlands. Alasdair Parker's co-authors include C. Geoffrey Woods, Fenella J. Kirkham, Andrew A. Mallick, Finbar O’Callaghan, Penny Fallon, Hannah B Edwards, Elizabeth Wraige, Tammy Hedderly, Vijeya Ganesan and Evangeline Wassmer and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Alasdair Parker

39 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alasdair Parker United Kingdom 16 285 239 238 221 160 40 995
Sabiha Aysun Türkiye 18 212 0.7× 32 0.1× 208 0.9× 176 0.8× 189 1.2× 59 903
Vandana Rai India 22 63 0.2× 128 0.5× 144 0.6× 43 0.2× 269 1.7× 79 1.3k
Şakìr Altunbaşak Türkiye 15 122 0.4× 37 0.2× 283 1.2× 211 1.0× 288 1.8× 91 809
Margitta T. Kampman Norway 25 173 0.6× 41 0.2× 239 1.0× 205 0.9× 75 0.5× 41 1.7k
Keith Pohl United Kingdom 17 158 0.6× 97 0.4× 30 0.1× 219 1.0× 63 0.4× 31 762
Rolf Fimmers Germany 18 82 0.3× 160 0.7× 114 0.5× 42 0.2× 83 0.5× 31 919
Şenay Haspolat Türkiye 14 135 0.5× 34 0.1× 168 0.7× 141 0.6× 117 0.7× 54 663
Surya Gupta United States 12 293 1.0× 27 0.1× 111 0.5× 132 0.6× 143 0.9× 24 959
Kálmán Kovács Hungary 24 208 0.7× 63 0.3× 25 0.1× 134 0.6× 93 0.6× 107 1.5k
Faruk İncecik Türkiye 14 69 0.2× 30 0.1× 184 0.8× 149 0.7× 160 1.0× 86 587

Countries citing papers authored by Alasdair Parker

Since Specialization
Citations

This map shows the geographic impact of Alasdair Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alasdair Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alasdair Parker more than expected).

Fields of papers citing papers by Alasdair Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alasdair Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alasdair Parker. The network helps show where Alasdair Parker may publish in the future.

Co-authorship network of co-authors of Alasdair Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Alasdair Parker. A scholar is included among the top collaborators of Alasdair Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alasdair Parker. Alasdair Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neal, Elizabeth, Elles van der Louw, Anita Devlin, et al.. (2024). Ketogenic diet registry for epilepsy: A cross-sectional feasibility study. European Journal of Paediatric Neurology. 53. 131–137. 1 indexed citations
2.
Amin, Sam, Katharine Forrest, Vishal Mehta, et al.. (2024). Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young people. Archives of Disease in Childhood. 109(8). 654–658. 1 indexed citations
3.
French, Courtney E., Helen Dolling, Karyn Mégy, et al.. (2022). Refinements and considerations for trio whole-genome sequence analysis when investigating Mendelian diseases presenting in early childhood. Human Genetics and Genomics Advances. 3(3). 100113–100113. 10 indexed citations
4.
Firth, Helen V., et al.. (2021). Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome. Molecular Genetics & Genomic Medicine. 9(12). e1708–e1708. 7 indexed citations
5.
Brown, Richard S., Hannah M. Grayton, John H. Livingston, et al.. (2020). Clinical and radiological characterization of novel FIG4 ‐related combined system disease with neuropathy. Clinical Genetics. 98(2). 147–154. 13 indexed citations
6.
Craiu, Dana, Leena Haataja, Katalin Hollódy, et al.. (2020). The training and organization of Paediatric Neurology in Europe: Special report of the European Paediatric Neurology Society & Committee of National Advisors. European Journal of Paediatric Neurology. 28. 6–15. 3 indexed citations
7.
McTaggart, James S., Afroditi D. Lalou, Nicholas J. Higgins, et al.. (2020). Correlation between the total number of features of paediatric pseudotumour cerebri syndrome and cerebrospinal fluid pressure. Child s Nervous System. 36(9). 2003–2011. 3 indexed citations
8.
Chitre, Manali, Michael S. Nahorski, Hamish Houston, et al.. (2018). PEHO syndrome: the endpoint of different genetic epilepsies. Journal of Medical Genetics. 55(12). 803–813. 10 indexed citations
9.
Steward, Charles A., Alasdair Parker, Berge A. Minassian, et al.. (2017). Genome annotation for clinical genomic diagnostics: strengths and weaknesses. Genome Medicine. 9(1). 49–49. 30 indexed citations
10.
Schoeler, Natasha E., Christin Eltze, Ruth Williams, et al.. (2017). Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trial. Trials. 18(1). 195–195. 18 indexed citations
11.
Nahorski, Michael S., Masato Asai, Emma Wakeling, et al.. (2016). CCDC88A mutations cause PEHO-like syndrome in humans and mouse. Brain. 139(4). 1036–1044. 16 indexed citations
12.
Ng, Kenrick, et al.. (2014). Annual review of children with tuberous sclerosis. Archives of Disease in Childhood Education & Practice. 100(3). 114–121. 13 indexed citations
13.
Mallick, Andrew A., Vijeya Ganesan, Fenella J. Kirkham, et al.. (2014). Diagnostic delays in paediatric stroke. Journal of Neurology Neurosurgery & Psychiatry. 86(8). 917–921. 79 indexed citations
14.
Mallick, Andrew A., Vijeya Ganesan, Fenella J. Kirkham, et al.. (2013). Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. The Lancet Neurology. 13(1). 35–43. 229 indexed citations
15.
Woods, C. Geoffrey & Alasdair Parker. (2013). Investigating microcephaly. Archives of Disease in Childhood. 98(9). 707–713. 108 indexed citations
16.
Kirkham, Fenella J., Philip Haywood, Megan Cox, et al.. (2011). Movement disorder emergencies in childhood. European Journal of Paediatric Neurology. 15(5). 390–404. 37 indexed citations
17.
Wang, Fengqiu, Yuhui Deng, Na Helian, et al.. (2007). Evolutionary Storage: Speeding up a Magnetic Disk by Clustering Frequent Data. IEEE Transactions on Magnetics. 43(6). 2295–2297. 5 indexed citations
18.
Parker, Alasdair. (2002). CURRENT MANAGEMENT IN CHILD NEUROLOGY, 2ND EDITION. Brain. 125(10). 2370–2370. 2 indexed citations
19.
Parker, Alasdair, et al.. (1998). Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Developmental Medicine & Child Neurology. 40(8). 517–519. 42 indexed citations
20.
Parker, Alasdair, Robert Robinson, & Peter Bullock. (1996). Difficulties in diagnosing intrinsic spinal cord tumours.. Archives of Disease in Childhood. 75(3). 204–207. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabiha Aysun Breakdown of academic impact, for papers by Vandana Rai Breakdown of academic impact, for papers by Şakìr Altunbaşak Breakdown of academic impact, for papers by Margitta T. Kampman Breakdown of academic impact, for papers by Keith Pohl Breakdown of academic impact, for papers by Rolf Fimmers Breakdown of academic impact, for papers by Şenay Haspolat Breakdown of academic impact, for papers by Surya Gupta Breakdown of academic impact, for papers by Kálmán Kovács Breakdown of academic impact, for papers by Faruk İncecik
Rankless by CCL
2026